Jabra Enhance Select 300 vs JLab Hear OTC

The Jabra Enhance Select 300 is a premium OTC hearing aid priced at $1,695 that earns an A grade with a SoundScore of 4.1/5 in our lab testing. This behind-the-ear device ranks #17 among 65 OTC hearing aids tested, placing it in the top 25% of its category. In our testing, the Enhance Select 300 demonstrates notable strengths in speech clarity for quiet environments, scoring 0.85 points above the OTC category average. Feedback handling is excellent at 5.0/5, and own-voice comfort scores a solid 3.5/5—nearly a full point above average for the category. Music streaming performance, while above average for OTC devices, remains mixed in absolute terms at 2.6/5. The device's main limitation appears in challenging listening environments. Speech-in-noise performance scored 1.5/5, which is low in absolute terms and essentially matches the category average. Users who frequently encounter noisy restaurants, busy offices, or crowded gatherings may find this a meaningful constraint. The Enhance Select 300 is best suited for individuals who primarily need improved hearing in quieter settings such as home conversations, one-on-one meetings, or watching television. It offers reliable streaming to both iPhone and Android devices, rechargeable batteries, and hands-free functionality. Shoppers seeking stronger noise performance at this price point may want to compare alternatives like the Lucid Tala or Audicus Omni 2, which scored higher overall in our testing.

The JLab Hear OTC is a budget-priced OTC hearing aid released in 2024, earning a B grade with a SoundScore of 3.5/5 in our lab testing. At $100, it represents one of the most affordable entry points into the OTC hearing aid market, ranking #36 of 65 devices in its category. This visible-in-ear device delivers a distinctive performance profile with clear strengths and weaknesses. Its standout feature is excellent music streaming quality, scoring 4.6/5—a remarkable 2.68 points above the category average. Feedback handling is equally impressive at 5.0/5, meaning users can expect stable performance without whistling during daily activities. These results suggest JLab leveraged its audio expertise from consumer earbuds in developing this product. However, speech clarity presents challenges. Speech in quiet scored 2.1/5 (0.67 points below category average), while speech in noise scored 1.0/5 (0.46 points below average). Own-voice comfort also measured low at 1.8/5. These limitations are significant for users prioritizing conversation clarity, which is typically the primary reason people seek hearing aids. The JLab Hear OTC is best suited for budget-conscious consumers who value music and media streaming alongside basic amplification, rather than those needing maximum speech intelligibility. Features include rechargeable batteries, iPhone and Android streaming, and hands-free functionality. Buyers seeking stronger speech performance in this price range may want to compare options like the higher-scoring Elehear Beyond or Apple AirPods Pro 2.